|
|
Documents > food and drug administration
FDADocs 5/5/2008 | 0 (0) | 17 | 0 | 0 | English
MEMORANDUM
DEPARTMENT OF HEALTH AND HUMAN SERVICES PUBLIC HEALTH SERVICE FOOD AND DRUG ADMINISTRATION Center for Drug Evaluation and Research
DATE:
January 29, 1999
FROM:
David Isom, Directo Office of Information Technology CDER, HFD-070
SUBJECT:
Docket 925-0251- Update Transmittal
TO:
Chief, Dockets Management Branch, HFA-305
Pursuant to ... more>>
FDADocs 5/5/2008 | 0 (0) | 20 | 0 | 0 | English
I~T~ UALTHAAND HUMAN AN SERVICE S ~ MEMORANDUM DBPART ~C AL~ ' FOOD AND DRUG ADMINISTRATION Center for Drug Evaluation and Researc h
DATE : FROM : James Shugars , Director Office of information Te ology CDER, HFD- 07 0
SUBJECT :
TO :
Docket 92S-0251 - Transmittal
Chief, Dockets M anagement Branch , HFA-305
Pursuant to 21 CFR Part 11 .2(b) (2), ... more>>
FDADocs 5/5/2008 | 0 (0) | 68 | 0 | 0 | English
FDADocs 5/5/2008 | 0 (0) | 71 | 0 | 0 | English
FDADocs 5/5/2008 | 0 (0) | 34 | 0 | 0 | English
DEPARTMENT OF HEALTH & HUMAN SERVICES
Food and Drug Administration Rockville, MD 20857
WARNING LETTER
October 11, 2002
Mr. John Q. Adams Product: Humibid Capsules Pediatric 300 mg Dear Sir/Madam: This letter is written in reference to the marketing by your firm of Humibid Capsules Pediatric 300 mg, a single ingredient guaifenesin extended releas ... more>>
FDADocs 5/5/2008 | 0 (0) | 17 | 0 | 0 | English
FDADocs 5/5/2008 | 0 (0) | 9 | 0 | 0 | English
Outline for Performing NDA Review
Susan Honig, Division of Oncology Drug Products
Page #
Objectives of the Review
1.0
InitialOrganization
2.0
Summary of Non-clinical disciplines
2.1
Regulatory Review
3.0
Review First Pivotal Trial
4.0
Other Clinical Trials and Non-Clinical Issues
5.0
Summary of Safety and Efficacy
6.0
Oncologic Drugs ... more>>
FDADocs 5/5/2008 | 0 (0) | 8 | 0 | 0 | English
FDADocs 5/5/2008 | 0 (0) | 11 | 0 | 0 | English
FDADocs 5/5/2008 | 0 (0) | 22 | 0 | 0 | English
FDADocs 5/5/2008 | 0 (0) | 11 | 0 | 0 | English
I
In Cooperation
With:
Overview
The U.S. Food and Drug Administrationhas undertaken manyInforma-
The U.S. Food andDrug Administration and PhRMA
Program
Chairpersons:
Krishan K. Arora, PhD, International irector, D ElectronicSubmissions, rug RegulatoryAffairs D Novartis Pharmaceuticals Corporation David C. Isom, Acting Director, Office of Inf ... more>>
FDADocs 5/5/2008 | 0 (0) | 15 | 0 | 0 | English
DEPARTMENT OF HEALTH & HUMAN SERVICES
Food and Drug Administration Rockviile MD 20857
I
UEC Q98 18 .
CERTIFIED MAIL RETURN RECEIPT REQUESTED
WARNING LETTER
Dr. Alex Krauer Chairman of the Board Novartis AG Postfach CH-4002 Basel, Switzerland from the During the period of August 24-28, 1998, an investigator U.S. Food and Drug Administration cond ... more>>
FDADocs 5/5/2008 | 0 (0) | 20 | 0 | 0 | English
FDADocs 5/5/2008 | 0 (0) | 9 | 0 | 0 | English
FDADocs 5/5/2008 | 0 (0) | 18 | 0 | 0 | English
| | | |
| results / page 15/25/50 |
Page: 28 of 34
|
...28...34
|
|